Himalaya Liv.52 DS

Liv.52 was launched in 1955, and millions of physicians worldwide recommend Liv.52 (tablet, syrup, and drops forms), for various hepatic disorders. Liv.52 is an extensively researched product of Himalaya Wellness Company. Various clinical studies such as open clinical studies, randomized controlled studies, meta-analysis, as well as independent investigator initiated clinical studies (including those carried out abroad) have reported that Liv.52 is beneficial in various hepatic conditions. The product has more than 300 research articles published in scientific journals.

Each herbal ingredient of Liv.52 is been analyzed as per the standards set by Pharmacopoeia. The battery of non-clinical toxicological studies (acute, subacute, chronic, genotoxicity, developmental, and reproductive toxicity studies) have further reinforced the safety of Liv.52, with a wide margin. We ensure consistent quality in every batch (as per WHO standards for herbal medicine). Himalaya’s manufacturing facility is GMP certified and audited at regular intervals by several regulatory agencies around the world, wherever our products are marketed. Also, Himalaya Wellness Company’s advanced Research and Development (R&D) Center is certified for Good Laboratory Practices (GLP) for following international OECD guidelines.

Directions for Use

Please consult your physician to prescribe the dosage that best suits the condition.

Available as a tablet or syrup.